AVCRFPharmaceutical PreparationsFiscal year ends December 31
Avricore Health Inc.
Financials through fiscal 2024, year ended Dec 31, 2024Last filing: 20-F on Jun 16, 2025
$0.00+0.00 (0.00%)
Close on Oct 16, 2026
Avricore Health Inc. revenue by segment
By business segment
By product or service
| Revenue | Q4 23 | Q3 23 | Q2 23 | Q4 22 | Q3 22 | Q2 22 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|
| Sale of products [Member] | C$878.82K | C$547.34K | C$160.84K | C$836.33K | C$519.94K | C$161.24K | 64.9% | +5.1% |
| Lease and service [Member] | C$475.58K | C$406.12K | C$387.21K | C$140.91K | C$52.29K | C$14.94K | 35.1% | +237.5% |
By region
From the segment and revenue-disaggregation notes of Avricore Health's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.